InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by LAMATTINA JOHN L, Director. Officer active across 2 companies, notably Immunome Inc.. Cumulatively, 7 disclosures have been recorded. Total volume traded: €10k. The latest transaction was filed on 10 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
01,004 shares0
Common Stock
SEC:0000886163-22-000079:0·
€137,3964,835 shares@ €28.41690.0037% mcap100.0% of flow
Common Stock
SEC:0000886163-21-000136·
€137,3964,835 shares@ €28.41690.0037% mcap50.0% of flow
Common Stock
SEC:0000886163-21-000136:0·
0630 shares0
Common Stock
SEC:0000886163-21-000089·
0630 shares0
Common Stock
SEC:0000886163-21-000089:0·
€5,103338 shares@ €15.0966100.0% of flow
Common Stock
SEC:0001104659-21-072617·
Ideal exit: 18 Feb 2022 (T+270)
€5,103338 shares@ €15.09660.0002% mcap50.0% of flow
Common Stock
SEC:0001104659-21-072617:0·
Ideal exit: 18 Feb 2022 (T+270)
7 of 7 declarations
About LAMATTINA JOHN L
John L. Lamattina is a Board Member at Immunome Inc. and Ligand Pharmaceuticals Inc. In this role, he contributes to overseeing the activities of the companies and making strategic decisions. Lamattina brings his expertise in corporate governance and biopharmaceuticals, which is essential for guiding the direction of the organizations. His commitment to innovation and research is an asset to the boards.
